Pages that link to "Q33905721"

The following pages link to Toll-like Receptor 4 and Hepatic Fibrogenesis (Q33905721):

Displaying 49 items.

• Probiotics for patients with hepatic encephalopathy (Q24235259) (← links)
• S-adenosylmethionine prevents the up regulation of Toll-like receptor (TLR) signaling caused by chronic ethanol feeding in rats (Q28388406) (← links)
• Cirrhosis and other liver disease in cystic fibrosis (Q28660820) (← links)
• Liver disease in cystic fibrosis: an update (Q28662082) (← links)
• Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice (Q30511815) (← links)
• Wnt2b attenuates HSCs activation and liver fibrosis through negative regulating TLR4 signaling (Q33822409) (← links)
• Retracted: High Mobility Group Box-1 Promotes the Proliferation and Migration of Hepatic Stellate Cells via TLR4-Dependent Signal Pathways of PI3K/Akt and JNK (Q34734165) (← links)
• Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease (Q34750494) (← links)
• Urinary metabolite profiling offers potential for differentiation of liver-kidney yin deficiency and dampness-heat internal smoldering syndromes in posthepatitis B cirrhosis patients (Q35034053) (← links)
• Influence of the CXCL1 rs4074 A allele on alcohol induced cirrhosis and HCC in patients of European descent (Q35049299) (← links)
• Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosis (Q35058280) (← links)
• Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis (Q35697286) (← links)
• Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidence (Q35786348) (← links)
• Metformin-mediated Bambi expression in hepatic stellate cells induces prosurvival Wnt/β-catenin signaling (Q35884151) (← links)
• Overexpression of pim-3 and protective role in lipopolysaccharide-stimulated hepatic stellate cells (Q35925507) (← links)
• MyD88 signaling pathway is involved in renal fibrosis by favoring a TH2 immune response and activating alternative M2 macrophages. (Q36434363) (← links)
• Toll‐like receptor signaling in liver regeneration, fibrosis and carcinogenesis (Q37125483) (← links)
• Probiotics and liver disease (Q37372411) (← links)
• Mechanisms of hepatic fibrogenesis (Q37865859) (← links)
• Peroxisome proliferator-activated receptor-γ cross-regulation of signaling events implicated in liver fibrogenesis (Q37959656) (← links)
• Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut (Q37962297) (← links)
• Immunological orchestration of liver fibrosis (Q38018539) (← links)
• Regulation of wound healing and organ fibrosis by toll-like receptors. (Q38065649) (← links)
• The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension (Q38074434) (← links)
• Toll-like receptors and liver disease (Q38151944) (← links)
• Role of innate immune response in non-alcoholic Fatty liver disease: metabolic complications and therapeutic tools (Q38209324) (← links)
• Pathophysiology of portal hypertension and its clinical links (Q38371453) (← links)
• Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg. (Q39333658) (← links)
• The gut microbiome and liver cancer: mechanisms and clinical translation. (Q39414187) (← links)
• Serum Toll-Like Receptor-2, Toll-Like Receptor-4 Levels in Patients with HBeAg-Negative Chronic Viral Hepatitis B. (Q40240357) (← links)
• Liver extracellular vesicles in health and disease (Q41895573) (← links)
• Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice (Q42023170) (← links)
• Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment (Q42368248) (← links)
• Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice. (Q43506762) (← links)
• Role of toll-like receptor 4 in mediating multiorgan dysfunction in mice with acetaminophen induced acute liver failure. (Q44928610) (← links)
• Resistin expression correlates with steatohepatitis in morbidly obese patients (Q45740496) (← links)
• Editorial: proton pump inhibitor therapy and liver disease progression-more cause for concern? (Q48371360) (← links)
• Possible involvement of Toll-like receptor 7 in the development of type 1 autoimmune pancreatitis. (Q53036183) (← links)
• Magnesium chenoursodeoxycholic acid ameliorates carbon tetrachloride-induced liver fibrosis in rats (Q54541850) (← links)
• Molecular pathways of nonalcoholic fatty liver disease development and progression (Q57807657) (← links)
• Mesenchymal stem cell transplantation improves chronic colitis-associated complications through inhibiting the activity of toll-like receptor-4 in mice (Q58786268) (← links)
• Stimulated hepatic stellate cell promotes progression of hepatocellular carcinoma due to protein kinase R activation (Q64114887) (← links)
• The role of CD14 and Toll-like receptor 4 of Kupffer cells in hepatic ischemia-reperfusion injury in rats (Q84077709) (← links)
• Liver fibrogenesis and genetic factors (Q84530249) (← links)
• Liver fibrosis (Q87669646) (← links)
• Toll-like receptor 4: a target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitis (Q90403144) (← links)
• Targeting SYK signaling in myeloid cells protects against liver fibrosis and hepatocarcinogenesis (Q91451300) (← links)
• Antifibrotic Effects of a Barbituric Acid Derivative on Liver Fibrosis by Blocking the NF-κB Signaling Pathway in Hepatic Stellate Cells (Q91972960) (← links)
• Protective effects of dihydroquercetin on an APAP-induced acute liver injury mouse model (Q92837637) (← links)